| 注册
首页|期刊导航|医学信息|2型糖尿病合并恶性肿瘤患者血清胰岛素及肿瘤坏死因子水平的检测及临床意义

2型糖尿病合并恶性肿瘤患者血清胰岛素及肿瘤坏死因子水平的检测及临床意义

周广举 王艳 杨秋 任伶俐 李玲 彭乙华 邓美红

医学信息Issue(24):27-27,28,2.
医学信息Issue(24):27-27,28,2.

2型糖尿病合并恶性肿瘤患者血清胰岛素及肿瘤坏死因子水平的检测及临床意义

Clinical Significance of Detection of Insulin and Tumor Necrosis Factor in Patients with Type 2 Diabetes Merging with Cancer

周广举 1王艳 1杨秋 1任伶俐 1李玲 1彭乙华 1邓美红2

作者信息

  • 1. 四川省川北医学院附属医院内分泌科,四川南充 637000
  • 2. 四川省川北医学院附属医院门诊注射室,四川南充 637000
  • 折叠

摘要

Abstract

Objective Investigating the levels of insulin and tumor necrosis factor expression in serum in patients with type 2 diabetes merging with cancer.Methods We col ected T2DM and cancer patients cases from January 2010 to October 2014 in our hospital,and col ected the general clinical data and laboratory test results according to the information,then compared the levels of insulin and tumor necrosis factor expression in serum in patients with type 2 diabetes merging with cancer,patients with diabetes alone and patients with cancer alone.Results The malignant tumor prevalence in T2DM was significantly higher than that in the general population,the TNF-αand insulin levels in serum in patients with diabetes merging with malignant tumor were significantly higher than those in patients with the diabetes alone,the TNF-αand insulin levels in serum in patients with diabetes merging with malignant tumor were significantly higher than those in the tumor alone group and the diabetes alone group. Conclusion It is necessary for the diabetes patients to monitor regularly the levels of TNF-αand insulin in serum,which may provide the clues of prediction and early diagnosis of tumors.

关键词

糖尿病/胰岛素/恶性肿瘤/肿瘤坏死因子

Key words

Diabetes/Insulin/Cancer/Tumor necrosis factor

引用本文复制引用

周广举,王艳,杨秋,任伶俐,李玲,彭乙华,邓美红..2型糖尿病合并恶性肿瘤患者血清胰岛素及肿瘤坏死因子水平的检测及临床意义[J].医学信息,2015,(24):27-27,28,2.

医学信息

1006-1959

访问量5
|
下载量0
段落导航相关论文